slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5.770 KRW | +0,70% | 0,00% | -6,94% |
15/05 | PharmGen Science, Inc. meldt winstresultaten voor het eerste kwartaal eindigend op 31 maart 2023 | CI |
Omzet 2022 | 151 mld. 112 mln. 104 mln. | Omzet 2023 | 167 mld. 124 mln. 115 mln. | Marktkapitalisatie | 111 mld. 82,85 mln. 76,72 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 70,06 mld. 52,12 mln. 48,27 mln. | Nettowinst (verlies) 2023 | 5,73 mld. 4,26 mln. 3,95 mln. | EV/omzet 2022 | 0,83 x |
Nettoschuld 2022 | 19,61 mld. 14,59 mln. 13,51 mln. | Nettoschuld 2023 | 526 mln. 391K 362K | EV/omzet 2023 | 0,67 x |
K/w-verhouding 2022 |
1,98
x | K/w-verhouding 2023 |
20,3
x | Werknemers | 250 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 86,78% |
1 dag | +0,70% | ||
Lopende maand | +0,35% | ||
1 maand | -0,52% | ||
3 maanden | -6,94% | ||
6 maanden | -13,36% | ||
Lopend jaar | -6,94% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hee-Deok Park
CEO | Chief Executive Officer | 56 | 27-03-19 |
Hye-Yeon Kim
CEO | Chief Executive Officer | 67 | - |
Nam-Hyun Ryu
BRD | Director/Board Member | 58 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Seung-Yeol Lee
BRD | Director/Board Member | 44 | - |
Hye-Yeon Kim
CEO | Chief Executive Officer | 67 | - |
Nam-Hyun Ryu
BRD | Director/Board Member | 58 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 5.770 | +0,70% | 31 111 |
27-03-24 | 5.730 | -1,72% | 53 201 |
26-03-24 | 5.830 | -1,69% | 62 377 |
25-03-24 | 5.930 | +1,54% | 104 668 |
22-03-24 | 5.840 | +1,21% | 141 233 |
slotkoers Korea S.E., 28 maart 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-6,94% | 77,59 mln. | |
+28,67% | 46,63 mld. | |
+19,30% | 22,49 mld. | |
+20,11% | 14,49 mld. | |
+0,55% | 12,98 mld. | |
+46,16% | 12,16 mld. | |
-2,44% | 7,69 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+7,80% | 5,15 mld. |